Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial.
Investigating the effects of lipid-lowering drugs on HDL subclasses has shown ambiguous results. This study assessed the effects of ezetimibe, simvastatin, and their combination on HDL subclass distribution.A single-center randomized parallel 3-group open-label study was performed in 72 healthy men...
Main Authors: | Heiner K Berthold, Manfredi Rizzo, Nadine Spenrath, Giuseppe Montalto, Wilhelm Krone, Ioanna Gouni-Berthold |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3963857?pdf=render |
Similar Items
-
Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo.
by: Ioanna Gouni-Berthold, et al.
Published: (2013-01-01) -
Association between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humans.
by: Heiner K Berthold, et al.
Published: (2011-01-01) -
Patterns and predictors of statin prescription in patients with type 2 diabetes
by: Böhm Michael, et al.
Published: (2009-05-01) -
PCSK9 Antibodies for the Treatment of Hypercholesterolemia
by: Ioanna Gouni-Berthold, et al.
Published: (2014-12-01) -
The relationship between high density lipoprotein subclass profile and plasma lipids concentrations
by: Tian Li, et al.
Published: (2010-10-01)